Company Overview of Chattem, Inc.
Chattem, Inc., along with its subsidiaries, designs, develops, manufactures, and markets over-the-counter health care products, toiletries, and supplements. It offers pain relief; skin and hair care; and health and wellness products. The company sells its products through retailers and distributors in the United States, Europe, Canada, and internationally, as well as online. Chattem, Inc. was formerly known as Chattem Drug and Chemical Company and changed its name to Chattem, Inc. in September 1978. The company was founded in 1879 and is headquartered in Chattanooga, Tennessee. As of February 8, 2010, Chattem, Inc. operates as a subsidiary of Sanofi.
1715 West 38th Street
Chattanooga, TN 37409
Founded in 1879
Key Executives for Chattem, Inc.
Chairman and Chief Executive Officer
Vice President of New Business Development
Compensation as of Fiscal Year 2014.
Chattem, Inc. Key Developments
Lauren Foster Sues Chattem Inc. on a Product's Packaging
Aug 31 14
The U.S. District Court for the Middle District of Florida denied in part dismissal of a complaint centered on a product's packaging. The complaint sufficiently alleged the falsity of a manufacturer's representation that its mouthwash rebuilds tooth enamel. Chattem Inc. manufactures ACT mouthwash. The product's packaging stated that ACT "rebuilds tooth enamel." Lauren Foster sued Chattem, claiming that ACT was misbranded because it is not possible to rebuild tooth enamel. The complaint alleged ACT only strengthens weak spots in tooth enamel. The complaint asserted claims for violation of Florida's Deceptive and Unfair Trade Practices Act (FDUTPA) and breach of the implied warranty of merchantability under state law and the federal Magnuson-Moss Warranty Act. Chattem moved to dismiss. First, Chattem argued the complaint did not plausibly state a claim that the phrase "rebuilds tooth enamel" was false or state a claim for damages. The complaint adequately alleged damages. Foster contended the misbranding of ACT rendered the product valueless. Alternatively, Foster pleaded that ACT was worth less than what she paid due to a premium charge for the misbranded features. Second, Chattem argued that dismissal of the breach of implied warranty claims was proper because Chattem was not in privity with Foster. Under Florida law, privity is established when a manufacturer makes direct representations to the purchaser. The district court observed that Foster did not allege any personal contact occurred between herself and a Chattem representative. Foster merely alleged she saw Chattem's packaging in the store and then purchased ACT. The district court concluded Foster could proceed with her claim under the FDUTPA. Because the complaint's allegations did not demonstrate privity, the district court dismissed the breach of implied warranty claims.
Chattem Announces Executive Changes
Jul 9 14
Chattem announced that Robert Long, it's executive vice president, has been appointed as president. John Stroud, also an executive vice president, was appointed to the new post of chief commercial officer. Long, who joined the company in 2006 and was its chief financial officer, will have a more expanded role as the company's new president. Stroud, who came to the company at about the same time, will oversee the commercial side of the business. Both Long and Stroud will continue to report to Zan Guerry, the company's chief executive officer.
Sanofi US Re-Introduces Rolaids(R) in the United States
Sep 16 13
Sanofi US and Chattem, Inc., have re-introduced Rolaids(R) to stores across the United States. The iconic brand returns after a three-year hiatus in the marketplace and follows Chattem's acquisition of Rolaids earlier in 2013. Rolaids is sold in retail stores across the United States and is available in both tablets and a new liquid form. The liquid is a first for the brand, as is new Ultra Strength formulation in both tablets and liquid. Ultra Strength Tablets and Liquid deliver Rolaids' strongest level of acid neutralization. Chattem will support the re-launch of Rolaids with a fully integrated marketing campaign featuring chef and restaurateur Guy Fieri. The campaign includes national television spots that include Fieri and re-establishes one of the most recognized advertising taglines of all-time -- How Do Spell Relief? R-O-L-A-I-D-S. Heartburn occurs when the opening between the stomach and esophagus malfunctions and allows stomach acid to enter the esophagus. More than two-thirds of all U.S. adults experience heartburn at least once per month. Chattem completed the acquisition of the worldwide rights to the Rolaids brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. on January 7, 2013.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|